Use access key #2 to skip to page content.
$26.75 -1.13 (-4.05%)
10/7/2008 3:45 PM

Vertex Pharmaceuticals, Inc. (VRTX)

CAPS Rating:
****

The Company is in the business of discovering, developing and commercializing small molecule drugs for the treatment of serious diseases.

View Ticker Page (VRTX)

Results 51 - 60 of 115 : « Previous   678910Next »

Recs

0

Avatar pjani06 (22.80) Submitted: 4/16/08 2:21 AM : Outperform Start Price: $25.87 VRTX Score: 28.69

In a climate where innovation has dried up, this company seems to deliver. Peers have been hit hard in this market climate however this one stood out and I believe for reason. Look for VRTX to lead long term.

Report this Post Replies: 0 | Reply | Permalink

Recs

0

Avatar zzlangerhans (98.62) Submitted: 4/15/08 3:17 AM : Underperform Start Price: $25.89 VRTX Score: -28.39

I won't spend much time knocking telaprevir or the rest of the pipeline, as it seems there's a lot of potential there. But a market cap of 3.6 billion? In this environment for biotech? With a quarterly burn of 100 million and no marketed products? It...

Report this Post Replies: 0 | Reply | Permalink

Recs

0

Avatar Smittyc5 (< 20) Submitted: 11/16/07 7:28 PM : Outperform Start Price: $25.63 VRTX Score: 35.52

pharma/bio play

Report this Post Replies: 0 | Reply | Permalink

Recs

0

Avatar RNZ100 (36.37) Submitted: 11/20/07 9:16 PM : Outperform Start Price: $23.10 VRTX Score: 45.89

Currently a bargain price

Report this Post Replies: 0 | Reply | Permalink

Recs

0

Avatar Biotech2008 (89.03) Submitted: 1/04/08 10:08 PM : Outperform Start Price: $21.26 VRTX Score: 55.29

missash@ 24.85

Report this Post Replies: 0 | Reply | Permalink

Recs

0

Avatar theyellowbox (73.07) Submitted: 2/22/08 12:26 AM : Outperform Start Price: $17.81 VRTX Score: 76.08

Insider Buying, Telaprevir past phase 2. Ready for some good news

Report this Post Replies: 0 | Reply | Permalink

Recs

0

Avatar supez2004 (93.16) Submitted: 3/03/08 1:07 AM : Outperform Start Price: $17.48 VRTX Score: 77.90

Beaten down -- potential for upside with results at EASL. boceprevir worries are overblown ...

Report this Post Replies: 0 | Reply | Permalink

Recs

0

Avatar ZBar (56.53) Submitted: 3/03/08 2:07 PM : Outperform Start Price: $17.51 VRTX Score: 77.64

This should bounce back with the economy

Report this Post Replies: 0 | Reply | Permalink

Recs

0

Avatar 8martini8 (91.40) Submitted: 3/04/08 4:14 PM : Outperform Start Price: $17.42 VRTX Score: 78.58

Telepravir now well on its way through testing and promises to be first to market. Stock beaten down severely over past 4 months, making this a terrific time to take a shot for outsized gains from this admittedly risky Biopharm.

Report this Post Replies: 0 | Reply | Permalink

Recs

0

Avatar PrincetonAl (< 20) Submitted: 3/06/08 11:16 PM : Outperform Start Price: $15.86 VRTX Score: 91.50

3 years ago this was at 10 and change. All the news since then has been progressing towards a successful blockbuster launch. Its only at 15. Yes, there is a ways to go ... but I see this as a double at least on a billion in expected sales minimum plu...

Report this Post Replies: 0 | Reply | Permalink

Featured Broker Partners